Assyro AI

Orange Book product · Brand (NDA)

PENNSAID

DICLOFENAC SODIUM

Brand (NDA)NDA 204623DISCN HORIZON

At a glance

Jan 16, 2014

Approved

Brand (NDA)

Application

Not listed

TE code

20

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 16, 2014

    12 yr 7 mo ago

  2. Today

  3. Patent 8563613 expires

    Listed drug product patent expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  4. Patent 8871809 expires

    Listed method-of-use patent (U-1614) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  5. Patent 9066913 expires

    Listed drug product patent expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  6. Patent 9101591 expires

    Listed drug product patent expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  7. Patent 9132110 expires

    Listed method-of-use patent (U-1488) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  8. Patent 9168304 expires

    Listed drug product patent expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  9. Patent 9168305 expires

    Listed method-of-use patent (U-1488) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  10. Patent 9220784 expires

    Listed method-of-use patent (U-1488) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  11. Patent 9339551 expires

    Listed method-of-use patent (U-1488) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  12. Patent 9339552 expires

    Listed drug product patent expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  13. Patent 9539335 expires

    Listed method-of-use patent (U-1614) expiration.

    Oct 17, 2027

    in 1 yr 4 mo

  14. Patent 8252838 expires

    Listed drug product patent expiration.

    Apr 21, 2028

    in 1 yr 10 mo

  15. Patent 8217078 expires

    Listed method-of-use patent (U-1477) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  16. Patent 8618164 expires

    Listed method-of-use patent (U-1477) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  17. Patent 8741956 expires

    Listed method-of-use patent (U-1435) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  18. Patent 9370501 expires

    Listed method-of-use patent (U-1614) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  19. Patent 9375412 expires

    Listed method-of-use patent (U-1614) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  20. Patent 9415029 expires

    Listed method-of-use patent (U-1614) expiration.

    Jul 10, 2029

    in 3 yr 1 mo

  21. Patent 8546450 expires

    Listed method-of-use patent (U-1435) expiration.

    Aug 09, 2030

    in 4 yr 2 mo

  22. Patent 8546450 expires

    Listed method-of-use patent (U-1436) expiration.

    Aug 09, 2030

    in 4 yr 2 mo

Pharmaceutical detail

Active ingredient

DICLOFENAC SODIUM

Strength

2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dosage form

SOLUTION

Route

TOPICAL

TE code

Not listed

Application

NDA 204623

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (20)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8563613Oct 17, 2027in 1 yr 4 mo
ProductU-1488
8871809Oct 17, 2027in 1 yr 4 mo
U-1614
9066913Oct 17, 2027in 1 yr 4 mo
ProductU-1488
9101591Oct 17, 2027in 1 yr 4 mo
ProductU-1488
9132110Oct 17, 2027in 1 yr 4 mo
U-1488
9168304Oct 17, 2027in 1 yr 4 mo
Product
9168305Oct 17, 2027in 1 yr 4 mo
U-1488
9220784Oct 17, 2027in 1 yr 4 mo
U-1488
9339551Oct 17, 2027in 1 yr 4 mo
U-1488
9339552Oct 17, 2027in 1 yr 4 mo
ProductU-1488
9539335Oct 17, 2027in 1 yr 4 mo
U-1614
8252838Apr 21, 2028in 1 yr 10 mo
ProductU-1489
8217078Jul 10, 2029in 3 yr 1 mo
U-1477
8618164Jul 10, 2029in 3 yr 1 mo
U-1477
8741956Jul 10, 2029in 3 yr 1 mo
U-1435
9370501Jul 10, 2029in 3 yr 1 mo
U-1614
9375412Jul 10, 2029in 3 yr 1 mo
U-1614
9415029Jul 10, 2029in 3 yr 1 mo
U-1614
8546450Aug 09, 2030in 4 yr 2 mo
U-1435
8546450Aug 09, 2030in 4 yr 2 mo
U-1436
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.